Volume 10, Issue 5 (Shenakht Journal of Psychology and Psychiatry 2023)
Shenakht Journal of Psychology and Psychiatry 2023, 10(5): 58-72 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kolah-Zari S, Mohammadi A, Rezaei F. The efficacy of integrated transdiagnostic treatment in reducing worry, anxiety, depressive and emotional regulation in patients with generalized anxiety disorder. Shenakht Journal of Psychology and Psychiatry 2023; 10 (5) :58-72
URL: http://shenakht.muk.ac.ir/article-1-2074-en.html
URL: http://shenakht.muk.ac.ir/article-1-2074-en.html
1- MSc, Department of Psychiatry, Kurdistan University of Medical Sciences, Sanandaj, Iran
2- Assistant Professor, Department of Psychiatry, Tehran University of Medical Sciences, Roozbeh Hospital, Tehran, Iran, Researcher at the University of Saskatchewan, Saskatchewan, Canada , Amohammadi@stu.iums.ac.ir
3- Professor, Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran
2- Assistant Professor, Department of Psychiatry, Tehran University of Medical Sciences, Roozbeh Hospital, Tehran, Iran, Researcher at the University of Saskatchewan, Saskatchewan, Canada , Amohammadi@stu.iums.ac.ir
3- Professor, Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran
Abstract: (701 Views)
Introduction: Generalized anxiety disorder (GAD) is a prevalent mental health condition, characterized by an individual’s excessive and persistent worry about various social situations. It is a common problem which can induce numerous physical and mental alterations in the person affected.
Aim: The current study aimed to evaluate the efficacy of an integrated transdiagnostic treatment approach in alleviating symptoms of worry, anxiety, and depression and improving emotional regulation in patients diagnosed with GAD.
Method: In this semi-experimental study, a pretest-posttest, control group design with a follow-up was employed. The research population consisted of all clients aged 18-51 years with GAD in Sanandaj, Iran, during 2018. The research sample comprised 20 patients diagnosed with GAD based on the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). These diagnoses were confirmed through structured interviews conducted by a psychiatrist and a clinical psychologist. The samples were selected via convenience sampling and randomly allocated into experimental and control groups. The research utilized several assessment tools, including the Beck Depression Inventory (1961), the Beck Anxiety Inventory (1988), the Pennsylvania Anxiety Inventory (1990), and the Emotional Regulation Inventory (2008). The collected data were analyzed using the analysis of covariance test in SPSS Version 24 software.
Results: According to the results, the integrated transdiagnostic treatment had an impact on reducing anxiety and depression. However, it was not effective in alleviating anxiety and improving emotional regulation in patients with GAD (P≤0.001).
Conclusion: The integrated transdiagnostic treatment method utilized in this study proved to be effective in alleviating worry and depression in patients diagnosed with GAD. Consequently, it is recommended for use in the therapeutic management of worry and depression symptoms in individuals suffering from GAD.
Aim: The current study aimed to evaluate the efficacy of an integrated transdiagnostic treatment approach in alleviating symptoms of worry, anxiety, and depression and improving emotional regulation in patients diagnosed with GAD.
Method: In this semi-experimental study, a pretest-posttest, control group design with a follow-up was employed. The research population consisted of all clients aged 18-51 years with GAD in Sanandaj, Iran, during 2018. The research sample comprised 20 patients diagnosed with GAD based on the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). These diagnoses were confirmed through structured interviews conducted by a psychiatrist and a clinical psychologist. The samples were selected via convenience sampling and randomly allocated into experimental and control groups. The research utilized several assessment tools, including the Beck Depression Inventory (1961), the Beck Anxiety Inventory (1988), the Pennsylvania Anxiety Inventory (1990), and the Emotional Regulation Inventory (2008). The collected data were analyzed using the analysis of covariance test in SPSS Version 24 software.
Results: According to the results, the integrated transdiagnostic treatment had an impact on reducing anxiety and depression. However, it was not effective in alleviating anxiety and improving emotional regulation in patients with GAD (P≤0.001).
Conclusion: The integrated transdiagnostic treatment method utilized in this study proved to be effective in alleviating worry and depression in patients diagnosed with GAD. Consequently, it is recommended for use in the therapeutic management of worry and depression symptoms in individuals suffering from GAD.
Type of Study: Research |
Subject:
Special
Received: 2023/06/11 | Accepted: 2023/10/21 | Published: 2023/11/1
Received: 2023/06/11 | Accepted: 2023/10/21 | Published: 2023/11/1
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
